Jaguar Health (JAGX) Financials: Revenue & Earnings

JAGX price $2.12 -0.12 -5.36%

Ticker
JAGX
Price
$2.12
Change
-0.12 -5.36%
Market cap ?
$4.12M
P/E ?
-0.00
Dividend yield ?
0.00%
Beta ?
-0.06
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
141523436118644161455775000938500043350001195600097610001168900011511000

Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for…

Fair value

JAGX fair value Not meaningful. Price $2.12.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare JAGX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-444.29—4.85M
2026-08-19-235.38-565.811.23M4.24M
2026-05-20-2.04-10.7120.27M3.67M
2026-04-07-3.14-1.493.23M4.21M
2025-11-12-2.20-1.783.08M3.73M
2025-08-14-3.59-2.502.98M3.27M
2025-05-15-5.84-3.792.21M2.82M
2025-03-31-2.77-2.773.50M3.10M
2024-11-13-9.19-0.363.07M3.90M
2024-08-13-530.25-0.182.72M3.40M
2024-05-14-472.50-236.252.35M3.00M
2024-04-01-315.00-220.502.30M2.61M
2023-11-13-4.95-11.072.81M2.46M
2023-08-14-94.50-344.252.68M2.28M
2023-05-15-1,258.53-1,012.501.97M3.90M
2023-03-24-1,800.61-1.463.26M2.00M
2022-11-14-81.00-50.623.15M3.55M
2022-08-22-4,751.11-148.502.92M3.10M
2022-05-10-15,837.05-1.972.62M1.60M
2022-03-11-3.49-1.012.09M1.62M
2021-11-17-10,690.01-1.91630.00K2.77M
2021-08-13-11,878.98-0.45385.00K385.00K
2021-05-17-11,878.98-0.231.24M3.35M
2021-03-31-5.06-3.382.58M7.40M
2020-11-16-24,945.85-1.242.77M2.11M
2020-08-13-34,449.03-1.693.17M2.65M
2020-05-15-66,522.26-2.59869.00K356.91K
2020-04-03-17,354.92-17.101.51M1.60M
2019-11-14-230,452.12-29,697.44972.78K607.99K
2019-08-14-1,079,798.88-666,410.521.71M597.16K
2019-05-21-1,495,255.68-1,578,325.441.59M1.68M
2019-04-10-1,612,075.51-384.751.60M2.20M
2018-11-19-5,067,255.36—1.13M—
2018-08-13-6,313,301.76—883.85K—
2018-05-15-6,227,118.72—804.36K—
2018-04-09-453.26—1.54M—
2017-11-2016,190,507.52-1,535.621.10M2.38M
2017-08-09-14,945,084.16-27,399,321.60896.52K900.00K
2017-05-15-34,871,864.32-45.36822.41K900.00K
2017-02-15-34,871,864.32-2.7028.88K1.71K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2025-12-11MICEK JOHNBuy7.38K——
2025-12-11MICEK JOHNBuy7.38K$1.4410.62K
2025-12-11King Steven R.Buy11.74K——
2025-12-11King Steven R.Buy11.74K$1.4416.91K
2025-12-11CONTE LISA ABuy28.59K——
2025-12-11CONTE LISA ABuy28.59K$1.4441.17K
2025-12-11Wolin Jonathan S.Buy11.74K——
2025-12-11Wolin Jonathan S.Buy11.74K$1.4416.91K
2025-12-11Chaturvedi Pravin RBuy11.74K——
2025-12-11Chaturvedi Pravin RBuy11.74K$1.4416.91K
2025-12-11BOCHNOWSKI JAMES JBuy6.36K——
2025-12-11BOCHNOWSKI JAMES JBuy6.36K$1.449.16K
2025-12-11Siegel Jonathan B.Buy7.38K——
2025-12-11Siegel Jonathan B.Buy7.38K$1.4410.62K
2025-12-11Jayasuriya AnulaBuy5.87K——
2025-12-11Jayasuriya AnulaBuy5.87K$1.448.45K
2025-12-11Lizak Carol R.Buy11.74K——
2025-12-11Lizak Carol R.Buy11.74K$1.4416.91K
2025-08-28Lincoln Alternative Strategies LLCOther0——
2025-06-24Siegel Jonathan B.Buy9.46K$5.5552.56K
2025-06-24Siegel Jonathan B.Buy18.26K$2.7049.31K
2025-06-24Siegel Jonathan B.Sell9.00K$5.5549.99K
2025-06-24MICEK JOHNBuy9.46K$5.5552.56K
2025-06-24MICEK JOHNBuy18.26K$2.7049.31K
2025-06-24MICEK JOHNSell9.00K$5.5549.99K
2025-06-24BOCHNOWSKI JAMES JBuy28.39K$5.55157.70K
2025-06-24BOCHNOWSKI JAMES JBuy54.79K$2.70147.92K
2025-06-24BOCHNOWSKI JAMES JSell27.00K$5.55150.00K
2025-06-24King Steven R.Buy3.79K$5.5521.03K
2025-06-24King Steven R.Buy7.30K$2.7019.72K
2025-06-24King Steven R.Sell3.60K$5.5520.00K
2025-06-24Chaturvedi Pravin RBuy3.79K$5.5521.03K
2025-06-24Chaturvedi Pravin RBuy7.30K$2.7019.72K
2025-06-24Chaturvedi Pravin RSell3.60K$5.5520.00K
2025-06-24Wolin Jonathan S.Buy9.46K$5.5552.56K
2025-06-24Wolin Jonathan S.Buy18.26K$2.7049.31K
2025-06-24Wolin Jonathan S.Sell9.00K$5.5549.99K
2025-06-24CONTE LISA ABuy9.46K$5.5552.56K
2025-06-24CONTE LISA ABuy18.26K$2.7049.31K
2025-06-24CONTE LISA ASell9.00K$5.5549.99K
2025-05-17King Steven R.Buy1——
2025-05-17King Steven R.Sell1——
2025-05-17CONTE LISA ABuy2——
2025-05-17CONTE LISA ASell2——
2025-03-31MICEK JOHNBuy9.00K$5.4348.87K
2025-03-31MICEK JOHNBuy9.00K$5.5549.99K
2025-03-31King Steven R.Buy3.60K$5.5520.00K
2025-03-31King Steven R.Buy3.60K$5.4319.55K
2025-03-31Siegel Jonathan B.Buy9.00K$5.5549.99K
2025-03-31Siegel Jonathan B.Buy9.00K$5.4348.87K
2025-03-31CONTE LISA ABuy9.00K$5.4348.87K
2025-03-31CONTE LISA ABuy9.00K$5.5549.99K
2025-03-31Wolin Jonathan S.Buy9.00K$5.5549.99K
2025-03-31Wolin Jonathan S.Buy9.00K$5.4348.87K
2025-03-31Chaturvedi Pravin RBuy3.60K$5.5520.00K
2025-03-31Chaturvedi Pravin RBuy3.60K$5.4319.55K
2025-03-31BOCHNOWSKI JAMES JBuy27.00K$5.55150.00K
2025-03-31BOCHNOWSKI JAMES JBuy27.00K$5.43146.62K
2025-03-31Lizak Carol R.Buy5.40K$5.4329.32K
2025-03-31Lizak Carol R.Buy5.40K$5.5530.00K
2024-10-08Lizak Carol R.Buy34.24K$1.2944.17K
2024-10-08Lizak Carol R.Buy4.28K——
2024-10-08Chaturvedi Pravin RBuy39.38K$1.2950.80K
2024-10-08Chaturvedi Pravin RBuy4.92K——
2024-10-08Wolin Jonathan S.Buy39.38K$1.2950.80K
2024-10-08Wolin Jonathan S.Buy4.92K——
2024-10-08CONTE LISA ABuy132.02K$1.29170.31K
2024-10-08CONTE LISA ABuy16.50K——
2024-10-08MICEK JOHNBuy26.50K$1.2934.19K
2024-10-08BOCHNOWSKI JAMES JBuy23.20K$1.2929.93K
2024-10-08Jayasuriya AnulaBuy21.00K$1.2927.09K
2024-10-08King Steven R.Buy39.38K$1.2950.80K
2024-10-08King Steven R.Buy4.92K——
2024-10-08Siegel Jonathan B.Buy26.50K$1.2934.19K
2024-05-17Chaturvedi Pravin RBuy871——
2024-05-17Chaturvedi Pravin RSell871——
2024-05-17Wolin Jonathan S.Buy871——
2024-05-17Wolin Jonathan S.Sell871——
2024-05-17Lizak Carol R.Buy431——
2024-05-17Lizak Carol R.Sell431——
2024-05-17King Steven R.Buy612——
2024-05-17King Steven R.Sell612——
2024-05-17CONTE LISA ABuy2.69K——
2024-05-17CONTE LISA ASell2.69K——
2024-04-05Chaturvedi Pravin RBuy134——
2024-04-05Chaturvedi Pravin RSell134——
2024-04-05Wolin Jonathan S.Buy89——
2024-04-05Wolin Jonathan S.Sell89——
2024-04-05Lizak Carol R.Buy60——
2024-04-05Lizak Carol R.Sell60——
2024-04-05King Steven R.Buy178——
2024-04-05King Steven R.Sell178——
2024-04-05CONTE LISA ABuy600——
2024-04-05CONTE LISA ASell600——
2023-08-14Jayasuriya AnulaBuy68.57K——
2023-08-14Siegel Jonathan B.Buy68.57K——
2023-08-14MICEK JOHNBuy68.57K——
2023-08-14BOCHNOWSKI JAMES JBuy76.61K——
2023-08-14Chaturvedi Pravin RBuy204.19K——
2023-08-14Wolin Jonathan S.Buy196.63K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 7, holders -3 vs prior quarter. Ownership 0.66%.

HolderSharesChangeChange %Value
UBS GROUP AG4.00K-108.91K-96.46%12.00K
TOWER RESEARCH CAPITAL LLC (TRC)1.16K-1.15K-49.81%3.48K
SBI SECURITIES CO., LTD.84-2.49K-96.73%252
BARCLAYS PLC5656New168
LEONTEQ SECURITIES AG5-183-97.34%15
WELLS FARGO & COMPANY/MN5-195-97.50%15
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC1-44-97.78%3
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0-45-100.00%0
SBI SECURITIES CO., LTD.0-2.57K-100.00%0
WELLS FARGO & COMPANY/MN0-200-100.00%0
BLACKROCK, INC.0-4-100.00%0
GEODE CAPITAL MANAGEMENT, LLC0-110.13K-100.00%0
TWO SIGMA SECURITIES, LLC0-12.55K-100.00%0
HRT FINANCIAL LP0-15.19K-100.00%0
TOWER RESEARCH CAPITAL LLC (TRC)0-2.31K-100.00%0
LEONTEQ SECURITIES AG0-188-100.00%0
UBS GROUP AG0-112.91K-100.00%0

Earnings and financials

Jaguar Health, Inc. (JAGX) trades at $2.12, with a market cap of $4.12M and a trailing P/E of -0.00. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
141523436118644161455775000938500043350001195600097610001168900011511000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Jaguar Health (JAGX) Financials: Revenue & Earnings

JAGX$2.12-0.12 -5.36%

$4.12M

Market Cap

-0.00

P/E

—

Forward P/E

—

Score

Price History